Xencor, Inc.
HETERODIMERIC ANTIBODIES THAT BIND CD3 AND TUMOR ANTIGENS
Last updated:
Abstract:
The present invention is directed to novel heterodimeric antibodies.
Status:
Application
Type:
Utility
Filling date:
18 Oct 2021
Issue date:
10 Feb 2022